4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0001104659-19-040966
Options or other derivatives
- Chief Operating Officer acquired 28,571 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Stuart Bryan Chief Operating Officer | 2019-07-18 | Grant or award · Stock Option (right to buy) | +28,571 | 28,571 | D: show line 1 in the form |
Loading xslF345X03/a4.xml…